Michel Sadelain - Concepedia

Author

Michel Sadelain

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

M SADELAIN, M Sadelain, M W J Sadelain, M W Sadelain, M. Sadelain, M.W. Sadelain, MICHEL SADELAIN, Michel Sadelain, Michel W J Sadelain, Michel W Sadelain

642

Publications

61.4K

Citations

105

H-Index

170

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Kettering University University of Pennsylvania

About

Michel Sadelain is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	111	23.1K
2	Health Sciences	15	19	1.1K
3	Engineering	13	13	3.8K
4	Allergy	7	7	2.5K
5	Natural Sciences	3	3	152

Michel Sadelain

220

Publications

47.8K

Citations

H-Index

Page 1

	Year	Citations
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Stuart M. Chambers, Christopher A. Fasano, Eirini P. Papapetrou, Nature Biotechnology Human EsInduced Pluripotent Stem CellSignal TransductionSignaling PathwayDual Inhibition	2009	3.6K
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia Jae H. Park, Isabelle Rivière, Mithat Gönen, New England Journal of Medicine	2018	2.6K
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Science Translational Medicine	2014	2.5K
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia Renier J. Brentjens, Marco L. Davila, Isabelle Rivière, Science Translational Medicine	2013	2.1K
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis, Nature Crispr/cas9 Enhances TumourTrac LocusEngineeringOff-target EffectGenetic Engineering	2017	1.7K
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Blood	2011	1.3K
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade Theodoros Giavridis, Sjoukje J. C. van der Stegen, Justin Eyquem, Nature Medicine Immune ActivationAdaptive Immune SystemImmunologyImmunologic MechanismCd4 T Cell Responses	2018	1.2K
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Luis A. Rojas, Zachary Sethna, Kevin C. Soares, Nature	2023	1.1K
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition Leonid Cherkassky, Aurore Morello, Jonathan Villena‐Vargas, Journal of Clinical Investigation	2016	1K
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor John Maher, Renier J. Brentjens, Gertrude Gunset, Nature Biotechnology AllergyT-regulatory CellImmunologyImmunologic MechanismT Cell Immunity	2002	997

Page 1